Sep 6, 2025, 12:52
Which Antiarrhythmics Increase Bleeding Risk with Xa Inhibitors?
Thrombosis & Haemostasis Journal (TH Open) shared a post on X:
“What is the risk of Major Bleeding During Concomitant Use of Antiarrhythmics and Oral Factor Xa Inhibitors? Choi et al. found that Amiodarone, Diltiazem and Verapamil were associated with high bleeding risk, while Dronedarone was not.”
Read more here.
Find similar posts on Hemostasis Today.
-
Apr 18, 2026, 01:1679th World Health Assembly: ‘Advancing Health Equity for Bleeding Disorders’ – WFH
-
Apr 18, 2026, 00:44Join leading experts for an evening symposium at the ASPHO Conference – ISTH
-
Apr 17, 2026, 17:41José Antonio García Erce: Hematology in 48 H Day 1 What You Need to Know for Clinical Practice
-
Apr 17, 2026, 17:23Alfonso J. Tafur: Endovascular Therapy Improves Post-Thrombotic Syndrome Outcomes at 6 Months
-
Apr 17, 2026, 17:09Hayley Taylor: Whatever Your Blood Type if You Can Donate Please Do It Because You Could Help Save a Life
-
Apr 17, 2026, 16:51Ney Carter Borges: Additive Cardiovascular Risk Reduction Through Dual Targeting of Lipoprotein(a) and Interleukin-6 Signalling
-
Apr 17, 2026, 16:08David McIntosh: African Healthcare and European Partnerships in Plasma Medicine
-
Apr 17, 2026, 16:05Ana Pedrero Gil: How Are Intraoperative PRBC Transfusions Associated with Postoperative Delirium in Adults
-
Apr 17, 2026, 16:00William Aird: The Satisfaction of Recognising the Symptom Patterns in Iron Deficiency